{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:03:02Z","timestamp":1790186582219,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"am","delay-in-days":195,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K08-HL171936"],"award-info":[{"award-number":["K08-HL171936"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015135","name":"Haemonetics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20-GM152326"],"award-info":[{"award-number":["P20-GM152326"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.amjsurg.2025.116476","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:09:20Z","timestamp":1749582560000},"page":"116476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Change in novel plasmin activated clotting time assay predicts hyperfibrinolysis, massive transfusion, and mortality in trauma in under 3 minutes"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3697-3185","authenticated-orcid":false,"given":"Elizabeth R.","family":"Maginot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolle K.","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trace B.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle S.","family":"Sextro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan C.","family":"Hiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flobater I.","family":"Gawargi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynold","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor L.","family":"Nydam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjsurg.2025.116476_bib1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jth.14450","article-title":"Trauma-induced coagulopathy: the past, present, and future","volume":"17","author":"Kornblith","year":"2019","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116476_bib3","first-page":"1177","article-title":"Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization","volume":"64","author":"Cotton","year":"2008","journal-title":"J Trauma"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116476_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00268-006-0653-9","article-title":"Coagulopathy: its pathophysiology and treatment in the injured patient","volume":"31","author":"Tieu","year":"2007","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/XCS.0000000000001027","article-title":"Differentiating pathologic from physiologic fibrinolysis: not as simple as conventional thrombelastography","volume":"239","author":"Moore","year":"2024","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.amjsurg.2025.116476_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000004526","article-title":"The tissue-plasminogen activator-challenged thromboelastography provides a comprehensive assessment of fibrinolysis in the severely injured","author":"Maginot","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116476_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/TA.0b013e31825c1234","article-title":"Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration","volume":"73","author":"Cotton","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116476_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2017.02.018","article-title":"Viscoelastic tissue plasminogen activator challenge predicts massive transfusion in 15 minutes","volume":"225","author":"Moore","year":"2017","journal-title":"J Am Coll Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116476_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jamcollsurg.2014.07.943","article-title":"Early diagnosis of clinically significant hyperfibrinolysis using thrombelastography velocity curves","volume":"219","author":"Pommerening","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.amjsurg.2025.116476_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib12","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial","volume":"156","author":"Guyette","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archsurg.1969.01340070049006","article-title":"Coagulation during and after orthotopic transplantation of the human liver","volume":"98","author":"Groth","year":"1969","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116476_bib14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.amjsurg.2020.08.018","article-title":"Detection of early allograft dysfunction at 30 min of reperfusion in liver transplantation: an intraoperative diagnostic tool with real time assessment of graft function","volume":"220","author":"Moore","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.amjsurg.2025.116476_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1749-6632.1992.tb51645.x","article-title":"Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver","volume":"667","author":"Otter","year":"1992","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116476_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.surg.2015.04.008","article-title":"Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock","volume":"158","author":"Moore","year":"2015","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/TA.0000000000000885","article-title":"Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients","volume":"80","author":"Chapman","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116476_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/TA.0000000000002941","article-title":"Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: a diagnostic tool to resolve an international debate on tranexamic acid?","volume":"89","author":"Barrett","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2025.116476_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.surg.2019.05.011","article-title":"Clot activators do not expedite the time to predict massive transfusion in trauma patients analyzed with tissue plasminogen activator thrombelastography","volume":"166","author":"Walker","year":"2019","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.amjsurg.2025.116476_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/SHK.0000000000001160","article-title":"TEG lysis shutdown represents coagulopathy in bleeding trauma patients: analysis of the PROPPR cohort","volume":"51","author":"Cardenas","year":"2019","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116476_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840160219","article-title":"Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period","volume":"16","author":"Bakker","year":"1992","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116476_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjsurg.2023.05.033","article-title":"Tissue plasminogen activator challenge thrombelastography is the most accurate assay in predicting the need for massive transfusion in hypotensive trauma patients","volume":"226","author":"Jiang","year":"2023","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jamcollsurg.2019.03.015","article-title":"Does tranexamic acid improve clot strength in severely injured patients who have elevated fibrin degradation products and low fibrinolytic activity, measured by thrombelastography?","volume":"229","author":"Moore","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"12","key":"10.1016\/j.amjsurg.2025.116476_bib24","article-title":"The effectiveness of prehospital administration of tranexamic acid in reducing mortality in trauma patients: an overview","volume":"15","author":"Javeed","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116476_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Gruen","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjsurg.2025.116476_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.amjsurg.2025.116476_bib27","first-page":"S139","article-title":"The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: a secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial","volume":"62","author":"Spinella","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.amjsurg.2025.116476_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jss.2017.04.028","article-title":"Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis","volume":"220","author":"Moore","year":"2017","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116476_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000002092","article-title":"Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner","volume":"86","author":"Barrett","year":"2019","journal-title":"J Trauma Acute Care Surg"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961025002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961025002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:20:36Z","timestamp":1762539636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961025002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S0002961025002995"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116476","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in novel plasmin activated clotting time assay predicts hyperfibrinolysis, massive transfusion, and mortality in trauma in under 3 minutes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116476"}}